Get 50% OFF This Monsoon!
Fabino Enterprises
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Fabino Life Sciences is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited' vide Special Resolution dated March 03, 2015. A fresh Certificate of Incorporation consequent to conversion was issued on March 21, 2015 by the Registrar of Companies, Delhi.
The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other wellness focused consumer products like, packing, trading, etc. The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. The Company export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by Company.
The Company operate a manufacturing plant at Sonipat, Haryana. The Company manufactures and pack products and market approximately 70+ products in the domestic market and have a portfolio of FMCG products for Overseas Markets. These products are being marketed under the respective trademarks and brands like 'Fabino' and 'Keepshine'. Fabino brand market mostly all pharmaceutical products including Tablets, Ointments Syrups etc for various medical treatments in allopathic and certain herbal range. Keepshine brand market Shampoo and Hair Maintenance products. Most of the Company product range is manufactured by third party manufacturers on made to order basis as per instructions or as per the manufacturer. These products are then marketed by Company. The products under this category are tablets, capsules, soft gelatin capsules, Gel, syrups, suspension, injections, Vitamin -C tablets, coffee, tea, etc.
The Company has obtained registration and patents for various products at becoming a strong intellectual property owning company in the future. Some of these products are manufactured by company in house at the processing centre in Sonipat Haryana, some of the products are manufactured at contract manufacturing facility in Haryana and other product range is manufactured by third party manufacturers on made to order basis as per instructions.
The marketing and distribution network in India and overseas comprises a specialized team of Marketing Executives, which enables the Company Promoters to market products to over 12 states across India. The Company also market products to various hospitals and medical institutions through their channel partners in different states, which constitute an important channel for the distribution of products. The domestic marketing infrastructure consists of dedicated teams & individuals associated with the Company directly and as channel partners, which formulate marketing and promotional strategies for their products. The Company currently supply in the Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa , Jharkhand , parts of West Bengal, Andhra Pradesh and Nepal.
To provide a larger range of services, the Company has started a new division with manufacturing units for herbal and ayurvedic products. It undertakes third party herbal and food supplement product manufacturing orders. The Ayurvedic/ Herbal business operations are supported by loan licensing facilities which are approved by relevant authorities. The Company have been awarded a G.M.P Certification for following Good Manufacturing Practices of Ayurveda / Siddha/ Unnani drugs under 'Schedule T' of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, capsule, Oils, Syrups and Powder.
Fabino Company is an ISO 9001:2015 certified in recognition to quality standards and accredited with certifications pertaining to quality, health and safety standards. The quality policy is focused on fulfilling customer requirements through reliable products aimed at meeting all regulatory requirements and through continual improvement of quality management systems. The third party manufacturer products undergo a qualification process throughout the entire value chain to ensure that quality products are being provided to customers. The quality control programs involve subjecting the manufacturing processes and quality management systems to periodic reviews and observations for various periods. Further, the Company ensures that third party manufacturing facilities are accredited with necessary approvals and provide quality output for customers.
Fabino Enterprises share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Fabino Enterprises indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Fabino Enterprises is valued compared to its competitors.
Fabino Enterprises PE ratio helps investors understand what is the market value of each stock compared to Fabino Enterprises 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Fabino Enterprises evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Fabino Enterprises generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Fabino Enterprises in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Fabino Enterprises shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Fabino Enterprises compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Fabino Enterprises over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Fabino Enterprises helps investors get an insight into when they can enter or exit the stock. Key components of Fabino Enterprises Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Fabino Enterprises shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Fabino Enterprises ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Fabino Enterprises provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Fabino Enterprises highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Fabino Enterprises .
The balance sheet presents a snapshot of Fabino Enterprises ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App